Study of INKmune in Patients With mCRPC (CaRe Prostate)
NCT06056791
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Cancer
Metastatic Castration-resistant Prostate Cancer
mCRPC
Interventions
BIOLOGICAL:
INKmune
Sponsor
Inmune Bio, Inc.